Allscripts Healthcare Solutions Stock Forecast, Price & News

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Allscripts Healthcare Solutions stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDRX, but not buy additional shares or sell existing shares.
View analyst ratings for Allscripts Healthcare Solutions or view top-rated stocks.

Wall Street analysts have given Allscripts Healthcare Solutions a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Allscripts Healthcare Solutions wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Allscripts Healthcare Solutions is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) released its earnings results on Wednesday, August, 4th. The software maker reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.06. The software maker had revenue of $373.70 million for the quarter, compared to analyst estimates of $372.51 million. Allscripts Healthcare Solutions had a trailing twelve-month return on equity of 7.06% and a net margin of 49.61%.
View Allscripts Healthcare Solutions' earnings history.

Allscripts Healthcare Solutions' stock was trading at $6.31 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MDRX stock has increased by 119.3% and is now trading at $13.84.
View which stocks have been most impacted by COVID-19.

Allscripts Healthcare Solutions announced that its Board of Directors has initiated a stock repurchase program on Wednesday, May 26th 2021, which permits the company to repurchase $350,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to purchase up to 14% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's board believes its stock is undervalued.

Allscripts Healthcare Solutions issued an update on its FY 2021 earnings guidance on Thursday, September, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.50 billion-$1.50 billion, compared to the consensus revenue estimate of $1.50 billion.

10 brokers have issued 1 year price targets for Allscripts Healthcare Solutions' stock. Their forecasts range from $11.00 to $19.00. On average, they expect Allscripts Healthcare Solutions' stock price to reach $15.75 in the next year. This suggests a possible upside of 13.8% from the stock's current price.
View analysts' price targets for Allscripts Healthcare Solutions or view top-rated stocks among Wall Street analysts.

796 employees have rated Allscripts Healthcare Solutions CEO Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among Allscripts Healthcare Solutions' employees.

Some companies that are related to Allscripts Healthcare Solutions include Cerner (CERN), Omnicell (OMCL), Cortexyme (CRTX), Vocera Communications (VCRA), HealthStream (HSTM), Computer Programs and Systems (CPSI), Athena Technology Acquisition (ATHN) and Mirage Energy (MRGE).
View all of MDRX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Allscripts Healthcare Solutions' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Jefferies Group LLC (0.00%), BlackRock Inc. (17.37%), Vanguard Group Inc. (11.99%), Dimensional Fund Advisors LP (8.81%), Fisher Asset Management LLC (4.03%) and Fuller & Thaler Asset Management Inc. (4.02%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Lisa Khorey, Michael Klayko, Paul Black and Richard J Poulton.
View institutional ownership trends for Allscripts Healthcare Solutions.

MDRX stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Tamarack Advisers LP, BNP Paribas Arbitrage SA, Nuveen Asset Management LLC, Deutsche Bank AG, Fisher Asset Management LLC, Renaissance Technologies LLC, and William Blair Investment Management LLC. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Lisa Khorey, Michael Klayko, and Paul Black.
View insider buying and selling activity for Allscripts Healthcare Solutions or view top insider-selling stocks.

MDRX stock was bought by a variety of institutional investors in the last quarter, including Jefferies Group LLC, Goldman Sachs Group Inc., JPMorgan Chase & Co., SG Americas Securities LLC, Invesco Ltd., Jefferies Group LLC, First Trust Advisors LP, and WINTON GROUP Ltd. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Paul Black, and Richard J Poulton.
View insider buying and selling activity for Allscripts Healthcare Solutions or or view top insider-buying stocks.

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MDRX stock can currently be purchased for approximately $13.84.

Allscripts Healthcare Solutions has a market capitalization of $1.73 billion and generates $1.50 billion in revenue each year. The software maker earns $700.41 million in net income (profit) each year or $0.56 on an earnings per share basis.

Allscripts Healthcare Solutions employs 8,400 workers across the globe.

The following companies are subsidiares of Allscripts Healthcare Solutions: HealthGrid, Practice Fusion, and ZappRx.

Allscripts Healthcare Solutions was founded in 1986.

The official website for Allscripts Healthcare Solutions is www.allscripts.com.

Allscripts Healthcare Solutions is headquartered at 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654.

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at (800) 334-8534 or via email at [email protected].